ATHENA, the Desktop Human "Body"
Multimedia
·
OSTI ID:1166958
- USDOE/OSTI
Creating surrogate human organs, coupled with insights from highly sensitive mass spectrometry technologies, a new project is on the brink of revolutionizing the way we screen new drugs and toxic agents. ATHENA, the Advanced Tissue-engineered Human Ectypal Network Analyzer project team, is developing four human organ constructs - liver, heart, lung and kidney - that are based on a significantly miniaturized platform. Each organ component will be about the size of a smartphone screen, and the whole ATHENA "body" of interconnected organs would fit neatly on a desk. "By developing this 'homo minutus,' we are stepping beyond the need for animal or Petri dish testing: There are huge benefits in developing drug and toxicity analysis systems that can mimic the response of actual human organs," said Rashi Iyer, a senior scientist at Los Alamos National Laboratory, the lead laboratory on the five-year, $19 million multi-institutional effort. The project is supported by the Defense Threat Reduction Agency (DTRA). Some 40 percent of pharmaceuticals fail their clinical trials, Iyer noted, and there are thousands of chemicals whose effects on humans are simply unknown. Providing a realistic, cost-effective and rapid screening system such as ATHENA with high-throughput capabilities could provide major benefits to the medical field, screening more accurately and offering a greater chance of clinical trial success.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1166958
- Country of Publication:
- United States
- Language:
- English
Similar Records
Project ATHENA Creates Surrogate Human Organ Systems
The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity
Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward
Multimedia
·
2015
·
OSTI ID:1185252
The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity
Journal Article
·
2010
· Toxicology and Applied Pharmacology
·
OSTI ID:21344956
Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward
Journal Article
·
1984
· Int. J. Radiat. Oncol., Biol. Phys.; (United States)
·
OSTI ID:6264554